-
Innovation Ranking
Innovation Ranking – Wacker Chemie AG
Wacker Chemie AG (Wacker), a subsidiary of DR. Alexander Wacker Familiengesellschaft mbH, is a chemical company that develops, manufactures and markets silicon and ethylene-related products. It offers a range of siloxanes, silicone fluids, silicone emulsions, resins, elastomers, pyrogenic silica and silanes. The company also manufactures binders and polymeric additives such as dispersible polymer powders and dispersions. It supplies customized biotech and catalog products for the fine chemical sector. Wacker also produces hyperpure polysilicon for semiconductors and the solar sector. The...
-
Company Insights
Innovation and Patenting activity of Wacker Chemie AG Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Wacker Chemie AG Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Sector Analysis
Mergers and Acquisitions (M&A) in the Contract Manufacturing Industry – Implications and Outlook – 2023 Edition
M and A In Pharmaceutical Contract Manufacturing Industry Report Overview During 2018–22, contract manufacturing organization (CMO) merger and acquisition (M&A) deal activity increased, and the targeted manufacturers have adopted specialized capabilities such as controlled substance and containment manufacture. Despite considerable macroeconomic challenges for pharma manufacturers, 2021–22 witnessed strong M&A activity and CMO valuations, although there was a slight decline in CMO M&A activity in 2022 due to rising inflation and interest rates. The Mergers and Acquisitions (M&A) in the Contract...
-
Company Profile
Wacker Chemie AG – Company Profile
Wacker Chemie AG (Wacker), a subsidiary of DR. Alexander Wacker Familiengesellschaft mbH, is a chemical company that develops, manufactures and markets silicon and ethylene-related products. It offers a range of siloxanes, silicone fluids, silicone emulsions, resins, elastomers, pyrogenic silica and silanes. The company also manufactures binders and polymeric additives such as dispersible polymer powders and dispersions. It supplies customized biotech and catalog products for the fine chemical sector. Wacker also produces hyperpure polysilicon for semiconductors and the solar sector. The...
Add to Basket -
Sector Analysis
COVID-19: Contract Pharmaceutical Development and Manufacturing Relationships
This report examines contract manufacturing agreements for vaccines and therapies targeting COVID-19. It reports that there are more than 1,000 vaccines and therapies in development for COVID-19, and 36 vaccines and therapies approved (or granted emergency use authorization) for COVID-19 (as of report publication). At the beginning of the pandemic, slightly more than half of these agreements were for vaccines; this proportion has risen and continues to rise, as several vaccines have proven their safety and efficacy, received approval, and...
-
Sector Analysis
Outlook for Viral Vector Contract Manufacturing – Gene Therapies, Cell Therapies, and COVID-19 Vaccines
The bio/pharmaceutical industry is experiencing a shortage of viral vectors, a component needed to produce gene therapies and gene-modified cell therapies, as well as certain COVID-19 vaccines that require a viral vector, notably those from AstraZeneca and Johnson & Johnson (J&J). This report reveals that viral vector production is limited by insufficient manufacturing capacity, an inefficient manufacturing process, and the requirement for complex specialist facilities. There are 14 therapies/vaccines that use a viral vector (gene therapies, gene-modified cell therapies, and...
-
Track & Monitor
Contract Small Molecule API Manufacturing Industry by the Numbers – 2019 PharmSource Edition
This report characterizes the contract small molecule active pharmaceutical ingredient (API) manufacturing industry through a number of quantitative dimensions, including number and type of participants, containment and controlled substance capabilities, and financial performance of the top public contract manufacturing organizations (CMOs). Contract Small Molecule API Manufacturing is critical for establishing an understanding of the small molecule API CMO industry and the features of some of the largest CMOs participating in the industry.